Medicines Formulary

Medicines A–Z

A

Drug name	NICE TAs	Comments
Apixaban	Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (TA275)	Second choice following diagnosis of AF - use in line with NICE Anticoagulant Initiation Flowchart for Anticoagulation in Atrial Fibrillation
Apixaban	Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (TA245)	Use following hip and knee surgery - full course of treatment supplied on discharge
Apomorphine (APO-go®)		Amber - specialist recommendation
Apomorphine (Dacepton®)		Specialist recommendation - solution for injection in cartridge
Apraclonidine 1% eye drops (preserv-free)		Only PF sympathomimetic
Apremilast	TA419 - Apremilast for treating moderate to severe plaque psoriasis TA433 - Apremilast for treating active psoriatic arthritis
Apremilast (Otezla®)		TA433 - Aprelimast for treating psoriatic arthritis
Aquadrate ® cream (10% urea)
Arachis oil enema
Arcing spring diaphraghm sizes 60–95mm (rising in 5mm)

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.